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Abstract
Objective: To estimate the prevalence of depressive symptoms and major depressive disorder, as
assessed in population-based cross-sectional studies of Brazilian adults.
Methods:We performed a systematic review of the literature. The major databases were searched up
through October 2013. Two researchers selected the studies, extracted the data, and assessed their
methodological quality. Meta-analyses were performed using random effects.
Results: Of the 2,971 records retrieved, we selected 27 studies that assessed the prevalence of
depression morbidity in 464,734 individuals (66% women). Eleven different screening tools were used
to assess depression morbidity. The prevalence of depressive symptoms was 14% (95% confidence
interval [95%CI] 13-16; I2 = 99.5%), whereas the 1-year prevalence of major depressive disorder was
8% (95%CI 7-10; I2 = 86.7%), and the lifetime prevalence of major depressive disorder was 17%
(95%CI 14-19; I2 = 91.6%). All rates were higher in women than in men. No causes of heterogeneity
could be identified.
Conclusion: Depression morbidity was common among Brazilian adults, and affects more women
than men. Inconsistencies across studies highlight the need for standardization of future research.
Clinicians should routinely investigate for the presence of depression morbidity in this population.
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Introduction
Depression is a public health concern that is associated
with functional impairment and high morbidity and
mortality. The total economic cost of depression is
estimated to be around 83 billion dollars in the United
States1 and 118 billion euros in Europe.2 Depressed
people experience limitations in their usual activities and
have higher health service utilization.3 The World Health
Organization estimates that over 300 million people have
depression, of whom less than half have access to
treatment.4 By 2020, depression is estimated to be the
second most common cause of disability. The prevalence
of depression morbidity is considered high and is
increasing.5 Elucidating the epidemiological aspects of
the disease may help subsidize planning and allocation of
investments to better assist this population by providing
information about its distribution and related factors.6 In
developing economies with fewer resources, such as
Brazil, this strategy is essential for the development of
adequate mental health care assistance.
Some epidemiological features of depression are well
recognized, such as the fact that more females than
males are affected7 and that it is more frequent in young
people and in the elderly.8 It has been postulated,
however, that geographic and economic factors may play
an important role in the epidemiology of depression, given
that the prevalence of depression is not similar in all
settings. One survey conducted in 10 countries suggests
that depression is more frequent in Western (3.0 to 5.8%)
than in Eastern civilizations (0.8 to 2.3%).9
In the last few years, several population-based surveys
to estimate the prevalence of depression-related morbid-
ity in the economically active adult population were
conducted in Brazil, but no summary of the findings of
these studies is available. A narrative review found that
the 1-month prevalence of depression ranged from 1.9 to
10.2% in Brazilian studies published between 1993 and
1998.10 One existing meta-analysis included only reports
in English through the year 2000, and did not include
any surveys conducted in Brazil.11 Other systematic
reviews conducted using Brazilian data included only the
elderly in their target population.12,13 Thus, meta-analytic
studies on the prevalence of major depressive disorder
and depressive symptoms among Brazilian adults are
needed.
To bridge this gap, the main aim of the current study
was to estimate the prevalence of major depressive
disorder and depressive symptoms among Brazilian
adults through a systematic review of the literature with
meta-analysis.
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Methods
The protocol for this reviewwas registered in the International
Prospective Register of Systematic Reviews (PROSPERO),
under registration number CRD42013003976.
Eligibility criteria
Eligible studies included cross-sectional population-
based studies that assessed the prevalence of depres-
sion morbidity (either major depressive disorder or
depressive symptoms) in the Brazilian adult population,
published on any date. In this review, we classified as
adults persons between the ages of 18 and 65 years. The
prevalence of major depressive disorder had to have
been measured using a validated instrument. If the study
assessed the prevalence of depression through only a
single question (self-reported depression, i.e., the pre-
sence of depression morbidity was informed by respon-
dents themselves), we considered that it was measuring
depressive symptoms. No pre-specified diagnostic cri-
teria for depression morbidity were applied; instead, each
study criterion was assessed. We did not exclude studies
on the basis of sample size.
Information sources and search strategy
The MEDLINE, Embase, Scopus, LILACS, and SciELO
databases were searched, as well as the Brazilian public
domain web portal (Portal Domı´nio Pu´blico), without
restrictions as to language or publication date. The last
search was run in October 2013. We screened the
references of relevant studies to identify potentially
eligible research.
The following search query was used for MEDLINE (via
PubMed): (‘‘depression’’[mesh] OR ‘‘depressive disor-
der’’[mesh] OR depression OR depresion OR depressa˜o)
AND (‘‘prevalence’’[mesh] OR prevalence OR prevaleˆn-
cia) AND (‘‘Brazil’’[mesh] OR Brazil OR Brazil). This
strategy was adapted to the other sources as required.
Study selection and data extraction process
Considering the eligibility criteria, two authors (MTS and
TFG) independently reviewed the titles and abstracts of
the retrieved studies. Disagreements were resolved by
consensus. The level of agreement between the
reviewers was assessed using a kappa test.14
Previously standardized forms were used to collect the
following relevant data from the studies: city, research date,
publications deriving from the study, sample size, tool used
to measure depression, use of two-step diagnosis, and
prevalence of depression or depressive symptoms in the
sample in both women and men. One author extracted the
data (MTS), and the other checked the extraction (TFG).
When available, the databases of the studies were
assessed. In these cases, we selected only the age range
of interest (18 to 65 years old) and the cases in which
the participants themselves responded regarding the
outcome of interest (i.e., proxy answering was excluded)
to mitigate the risk of recall bias.15
Assessment of the quality of included studies
The critical appraisal tool proposed by Loney et al.16 for
prevalence studies was used to assess study quality.
This tool contains eight criteria: 1) adequate sampling; 2)
unbiased sampling frame; 3) adequate sample size; 4)
standard measures of outcomes; 5) unbiased assessors
of outcomes; 6) adequate response rate with refusals
described; 7) prevalence presented with confidence
intervals and by relevant subgroups; and 8) study
subjects described and appropriate for the research
question. For each criterion met, the study received one
point, for a maximum score of eight, which indicates the
studies of highest quality in the present review.
For the third quality criterion (adequate sample size),
we considered the sample size to be adequate if it was
calculated for the study on the basis of local population
estimates or if it was higher than 1,000. This minimum
sample size was calculated to allow outcome assessment
using simple random sampling, with an estimated rate of
depressive symptoms of 10%, confidence level of 95%,
and precision of 1.8%, resulting in a sample of 1,068
subjects.17 As all quality criteria, the sample size criterion
was not used to exclude studies.
Data analysis
The primary outcome was the prevalence of depression
morbidity (depressive symptoms or major depressive
disorder), with a 95% confidence interval (95%CI). We
pooled the available estimates for lifetime, 1-year lifetime,
and point prevalence of each outcome. Meta-analyses
were calculated using a random effects model and
weighted by inverse variance.18 Statistical heterogeneity
across the results of the selected studies was assessed
by chi-square test at the p , 0.10 significance level,19
and the magnitude of the inconsistency was estimated
using the I-square (I2) statistic.
To identify the causes of heterogeneity, we performed
meta-regression analyses using a restricted maximum
likelihood estimators method, with the Knapp & Hartung
test.20 The variables tested were sample size, quality
assessment score, proportion of women, use of a
validated tool for outcome assessment, and lower age
of inclusion in the study. The presence of the small-study
effect, i.e., a tendency of studies with smaller sample size
to overestimate the global effect, was assessed by
inspecting the asymmetry funnel plot and using Egger’s




The literature search retrieved 2,971 records, of which
821 were duplicates, resulting in 2,150 unique records.
The independent reviewers selected 51 records10,22-70
for full-text assessment (kappa = 0.79; 95%CI 0.68-0.90).
The reasons for exclusion are presented in Figure 1.
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Study characteristics
We included 27 studies that were published in 42 dif-
ferent reports (Table 1).22-63 For simplicity, we named
each study after the location where the research
was conducted. A total of 464,734 persons were
interviewed, of whom 304,374 (65.5%) were females.
Most of the surveys included persons 18 years old
and older.22-29,36-38,40,41,43,44,50-52,55-63 Three studies
did not primarily aim to assess the prevalence of
depression.30,35,47 Six national studies were included.23-30
Nine studies were conducted in the Southeast
region,22,31-33,43-45,50-63 eight in the South region,31-42,46
two in the Northeast region47-49 and one in the Mid-West
region of Brazil.31-33 Eight studies were conducted in
the 1990s.22-24,31-33,41,47
All studies used the official census for the sampling
frame and employed probability sampling: one study used
a random sample from the whole population,22 whereas
the others employed complex sampling, with one or
more stages. Two studies had fewer than 1,000
participants.35,47 Ten studies did not report participant
losses.23-28,30,35,45,48,49,53,62,63
To screen for the prevalence of depressive symptoms,
nine studies considered self-reported depression,23-
28,30,34,46,47,53 and 11 used the following tools: 1) Adult
Psychiatric Morbidity Questionnaire (Questiona´rio de
Morbidade Psiquia´trica de Adultos, QMPA)31-33,48,49;
2) Beck Depression Inventory (BDI)35,62,63; 3) Center
for Epidemiologic Studies Depression Scale (CES-D)29;
4) Composite International Diagnostic Interview Short-
Form (CIDI SF)54; 5) Edinburgh Postnatal Depression
Scale (EPDS)42; 6) Patient Health Questionnaire (PHQ-
9)40; and 7) Primary Care Evaluation of Mental Disor-
ders (PRIME-MD).45 The seven studies that screened
for major depressive disorder used the following
tools: the Composite International Diagnostic Inter-
view (CIDI),22,43,44,50-52,55-61 the Mini-International Neuro-
psychiatric Interview (MINI),36-39 and the DSM-IV.41
The mean quality score was 5.8. Three studies scored
fewer than five points.25,26,30,53 Due to the absence of
raw data, three studies could not be included in the
meta-analysis,31-33 and five did not stratify results
by sex, precluding their inclusion in the subgroup
analysis.25,26,30,40,46,54
Depressive symptoms
The overall prevalence of depressive symptoms in the
whole population surveyed in the studies was 14%
(95%CI 13-16; I2 = 99.5%; Figure 2). Table 2 shows the
results of subgroup analysis for this outcome. Prevalence
was significantly higher among women than in men.
Lifetime prevalence of depressive symptoms was
assessed in one study54 and was higher than that
observed in studies that measured point prevalence.
The point estimate of self-reported depressive symptoms
was lower than that measured by other tools.
The meta-regression analysis performed to investigate
the high heterogeneity across the results of the studies
did not find the following factors to be possible causes:
proportion of women, quality score, use of validated
screening tool, urban or rural area, minimum age for
inclusion, or year of research.
Visual inspection of the funnel plot revealed some
asymmetry in the distribution of study results (Figure 3).
However, the presence of the small-study effect was
rejected by Egger’s test (p = 0.051).
One-year prevalence of major depressive disorder
The 1-year prevalence of major depressive disorder was
8% (95%CI 7-10; I2 = 86.7%) among the adults surveyed
in five studies (Figure 4A).22,43,44,50-52,55-61 All five studies
used the CIDI as a screening tool. The prevalence was
higher among women (11.3%; 95%CI 9.4-13.2; I2 =
81.7%) and lower among men (4.0%; 95%CI 2.8-5.3; I2 =
76.1%). All of the estimates had high heterogeneity. Due
to the small number of studies, the causes of hetero-
geneity could not be explored through sensitivity analysis
or meta-regressions.
Lifetime prevalence of major depressive disorder
The lifetime prevalence of major depressive disorder was
assessed in four studies: three used the CIDI as a
screening tool, 43,44,55-61 and one used the DSM-IV.41
Figure 1 Study search, selection, and inclusion flowchart.
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The prevalence was 17% (95%CI 14-19; I2 = 91.6%;
Figure 4B) and was higher in the female subgroup
(21.6%; 95%CI 18.5-24.7; I2 = 86.0%) than in the
male subgroup (9.7%; 95%CI 7.5-11.8; I2 = 80.6%).
High heterogeneity was present in all estimates, and the
causes could not be investigated due to the small number
of studies.
Discussion
Depression morbidity was shown to be common among
Brazilian adults. The polled data show that one in seven
adults has depressive symptoms and that one in 12
adults has 12-month major depressive disorder. The
prevalence was twice as high in women as in men for
depressive symptoms, and three times higher for the 1-
year prevalence of major depressive disorder. The
findings were highly heterogeneous, which reduces the
confidence of the estimates.
Limitations
The high heterogeneity found may reflect differences
across study settings: studies were conducted in different
regions of Brazil that have distinct economic profiles,
employed diverse screening tools, and had dispropor-
tionate sex distributions. The interviews took place during
distinct periods of time, which may also have contributed
to the heterogeneity found, as depression morbidity may
have increased from one time point to another.5
The polled results may be overestimates: several
studies were conducted in large urban centers, a factor
associated with higher depression rates.58 In addition, the
demographic transition in Brazil over the past years,71
with dramatic growth of the middle class, may also have
influenced the results found, as depression is more
common in lower social strata.72
To mitigate potential bias, we performed sensitive
searches, and the results were assessed by independent
researchers. All of the included studies were population-
based and were assessed for methodological quality. If
feasible, the microdata of the studies were assessed for
the degree of compliance with the eligibility criteria used
in the present review.23 The factors potentially associated
with high heterogeneity were assessed through meta-
regression analyses.
Interpretation and generalizability
One systematic review of worldwide studies found a lower
12-month prevalence (4%) for major depressive disorder
Table 1 Characteristics of the included studies
Study Area Year
Age range







Bambuı´, MG22 urban 1996-1997 o 18 CIDI disorder 1,041 56.6 7
Brazil (PNAD)23,24 mixed 1998 18-65 self-report symptom 135,932 74.1 5
Brazil (WHS)25,26 mixed 2003 o 18 self-report symptom 5,000 12.3 4
Brazil (PNAD)23,27,28 mixed 2003 18-65 self-report symptom 120,203 66.2 5
Brazil (Brazilian alcohol survey)29 mixed 2005-2006 o 14 CES-D symptom 3,007 57.2 6
Brazil (PNAD)23,28 mixed 2008 18-65 self-report symptom 150,727 63.4 5
Brazil (racial inequity)30 mixed 2008 o 20 self-report symptom 3,863 34.4 4
Brası´lia, DF31-33 urban 1990-1991 o 15 QMPA symptom 2,345 53.7 6
Floriano´polis, SC34 urban 2009 20-59 self-report symptom 1,720 55.6 6
Joac¸aba, SC35 urban 2005 20-59 BDI symptom 707 60.0 5
Pelotas, RS36-39 urban 2007 18-24 MINI disorder 1,560 56.4 7
Pelotas, RS40 urban 2012 o 20 PHQ-9 symptom 2,925 58.9 6
Porto Alegre, RS31-33 urban 1990-1991 o 15 QMPA symptom 2,384 54.9 6
Porto Alegre, RS41 urban 1996-1998 o 18 DSM-IV disorder 1,174 56.1 7
Porto Alegre, RS42 urban 2009 o 20 EPDS symptom 3,391 55.9 7
Rio de Janeiro, RJ43,44 urban 2007-2008 15-75 CIDI disorder 1,208 56.5 6
Rio de Janeiro, RJ45 urban 2008 o 35 PRIME-MD symptom 1,249 100.0 5
Rio Grande, RS46 mixed 2000 o 15 self-report symptom 1,259 53.9 5
Salvador, BA47 mixed 1998 40-70 self-report symptom 513 0.0 5
Salvador, BA48,49 urban 2001 o 20 QMPA symptom 2,306 54.3 6
Sa˜o Paulo, SP31-33 urban 1990-1991 o 15 QMPA symptom 1,742 51.5 6
Sa˜o Paulo (catchment area study)50-52 urban 1994-1996 o 18 CIDI disorder 1,464 57.5 8
Sa˜o Paulo (ISA-SP, ISA-Capital)53 urban 2001-2003 all ages self-report symptom 8,317 52.3 4
Sa˜o Paulo (GENACIS)54 urban 2005-2007 20-64 CIDI SF symptom 2,083 58.3 6
Sa˜o Paulo (megacity study)55-61 urban 2005-2007 o 18 CIDI disorder 5,037 56.6 7
Sa˜o Paulo, SP (EPISONO)62,63 urban 2007 20-80 BDI symptom 1,042 53.5 6
Sa˜o Paulo, SP44 urban 2007-2008 15-75 CIDI disorder 2,536 59.1 6
BDI = Beck Depression Inventory; CES-D = Center for Epidemiologic Studies Depression Scale; CIDI = Composite International Diagnostic
Interview; CIDI SF = Composite International Diagnostic Interview Short-Form; EPDS = Edinburgh Postnatal Depression Scale; EPISONO =
Sa˜o Paulo Epidemiologic Sleep Study; GENACIS = Gender, Alcohol, and Culture International Study; ISA = Inque´rito de Sau´de do Estado de
Sa˜o Paulo (Health Survey - State of Sa˜o Paulo); ISA-Capital = Inque´rito Multiceˆntrico de Sau´de no Municı´pio de Sa˜o Paulo (Multicenter
Health Survey - City of Sa˜o Paulo); ISA-SP = Inque´rito Multiceˆntrico de Sau´de no Estado de Sa˜o Paulo (Multicenter Health Survey - State of
Sa˜o Paulo); MINI = Mini-International Neuropsychiatric Interview; PNAD = Pesquisa Nacional por Amostra de Domicı´lios (National
Household Sample Survey); PHQ-9 = Patient Health Questionnaire; PRIME-MD = Primary Care Evaluation of Mental Disorders; QMPA =
Questiona´rio de Morbidade Psiquia´trica de Adultos (Adult Psychiatric Morbidity Questionnaire); WHS = World Health Survey.
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than that observed in the present review, and found
similar results for depressive symptoms (12%); the
estimates were also higher in women than in men and
significantly heterogeneous.73 The point prevalence of
major depressive disorder is higher in South Asia, Africa
and the Middle East, and Eastern Europe. Individual,
large-population studies (over 20,000 participants) have
also reported lower estimates: in the United States, the 1-
year prevalence of major depressive disorder was 5%,
and the lifetime prevalence was 13%74; in Western
Europe, the 1-year prevalence of major depressive
disorder was 4%, and the lifetime prevalence was 13%.75
The literature in the field also shows that people with
depression have a poorer quality of life, are more likely to
have other diseases, and have a higher utilization of
health care services – outcomes that increase the costs
to health care systems.76 Depressive individuals are
less productive and have higher rates of absenteeism,
Table 2 Subgroup analysis of the prevalence of depressive symptoms








Female 1123-29,34,42,45,46,48,49,54 285,752 22 (20-24) 99.6 , 0.001
Male 1123-29,34,42,46-49,54 144,634 9 (8-11) 99.3 , 0.001
Time of outcome
Lifetime 154 2,083 22 (20-24) - -
Point 1623-30,34,35,42,45-49,53,62,63 442,036 15 (14-17) 99.6 , 0.001
Screening tool
Self-reported 923-28,30,34,46,47,53 427,021 11 (14-17) 99.6 , 0.001
BDI 235,62,63 1,624 8 (2-14) 94.9 , 0.001
CES-D 129 3007 28 (27-30) - -
CIDI-SF 154 2083 22 (20-24) - -
EPDS 142 3391 16 (15-17) - -
PHQ-9 140 2925 20 (19-22) - -
PRIME-MD 145 1249 46 (43-48) - -
QMPA 143,44 2306 12 (11-14) - -
BDI = Beck Depression Inventory; CES-D = Center for Epidemiologic Studies Depression Scale; CIDI SF = Composite International
Diagnostic Interview Short-Form; EPDS = Edinburgh Postnatal Depression Scale; PHQ-9 = Patient Health Questionnaire; PRIME-MD =
Primary Care Evaluation of Mental Disorders; QMPA = Questiona´rio de Morbidade Psiquia´trica de Adulto (Adult Psychiatric Morbidity
Questionnaire).
Figure 2 Prevalence of depressive symptoms among adults surveyed in Brazilian population-based studies. ES (95%CI) =
effect size (95% confidence interval); EPISONO = Sa˜o Paulo Epidemiologic Sleep Study; GENACIS = Gender, Alcohol and
Culture International Study; ISA = Inque´rito de Sau´de do Estado de Sa˜o Paulo (Health Survey - State of Sa˜o Paulo); PNAD =
Pesquisa Nacional por Amostra de Domicı´lios (National Household Sample Survey); WHS = World Health Survey.
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which has a negative impact on the economy of their
communities.77,78 These persons also exhibit high-risk
behaviors, such as alcohol and tobacco use, a sedentary
lifestyle, and unhealthy eating habits.5,79,80
Future research should take into account these
variables and focus on Brazilian regions that have been
less extensively studied, such as the North, Northeast
and Mid-West, and should include areas of lower
population density, such as rural areas. Concentrated
efforts towards developing a tool that has adequate
sensitivity and specificity, is easy to administer, and does
not require a second-stage interview are essential to
improve the quality and consistency of information
obtained from research. The health supplement of the
Brazilian National Household Sample Survey (Pesquisa
Nacional por Amostra de Domicı´lios, a countrywide
survey conducted by the Brazilian Institute of Geog-
raphy and Statistics every 5 years, interviewing over
150,000 persons each time)23 could fulfill this demand if it
included data from only the participants who answer the
interview questions and used a validated tool to screen
for depression morbidity. Further evidence on factors
associated with depression in the Brazilian population
could be provided by studies that explore variables such
as religiosity, violence, sexual orientation, eating habits,
sedentary lifestyle, and involvement in cultural activities,
leisure, and hobbies.
Figure 3 Funnel plot of the small-study effect: prevalence of
depressive symptoms in each study by the standard error
(s.e.) of the studies.
Figure 4 One-year (A) and lifetime (B) prevalence of major depressive disorder among adults surveyed in Brazilian
population-based studies. ES (95%CI) = effect size (95% confidence interval).
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Conclusion
Depressive symptoms and major depressive disorder, as
assessed in population-based studies, are common
among the adult population of Brazil. The prevalence of
all outcomes was higher in women than in men. In terms
of clinical practice and healthcare policy, the present
results highlight the need for standardization in the clinical
investigation of depression morbidity in this population.
Future research should focus on less-studied regions of
Brazil, such as the North, Northeast and Mid-West, where
very few studies have been conducted. Future studies
should also employ validated tools with adequate
accuracy and explore the effects of socio-cultural factors.
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